129 related articles for article (PubMed ID: 34214600)
1. PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high-fat diet conditions.
Onodera T; Ghazvini Zadeh E; Xu P; Gordillo R; Guo Z; Joffin N; Yu B; Scherer PE; Li WH
J Lipid Res; 2021; 62():100095. PubMed ID: 34214600
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.
Kim Y; Lim JH; Kim EN; Hong YA; Park HJ; Chung S; Choi BS; Kim YS; Park JY; Kim HW; Park CW
Cell Death Dis; 2022 Mar; 13(3):282. PubMed ID: 35351872
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet.
Cao Z; Ma B; Cui C; Zhao J; Liu S; Qiu Y; Zheng Y; Gao M; Luan X
Poult Sci; 2022 Apr; 101(4):101708. PubMed ID: 35150940
[TBL] [Abstract][Full Text] [Related]
5. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
6. The adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.
Nicolas S; Rochet N; Gautier N; Chabry J; Pisani DF
Metabolism; 2020 Feb; 103():154027. PubMed ID: 31778708
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
[TBL] [Abstract][Full Text] [Related]
8. An adiponectin-S1P axis protects against lipid induced insulin resistance and cardiomyocyte cell death via reduction of oxidative stress.
Botta A; Liu Y; Wannaiampikul S; Tungtrongchitr R; Dadson K; Park TS; Sweeney G
Nutr Metab (Lond); 2019; 16():14. PubMed ID: 30828353
[TBL] [Abstract][Full Text] [Related]
9. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
10. Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese mice.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
Sci Rep; 2021 Feb; 11(1):2923. PubMed ID: 33536560
[TBL] [Abstract][Full Text] [Related]
11. Targeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes.
Li WH
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144859
[TBL] [Abstract][Full Text] [Related]
12. AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21-mediated time-dependent mechanisms.
Wang Y; Liu H; Zhang R; Xiang Y; Lu J; Xia B; Peng L; Wu J
J Biol Chem; 2022 Mar; 298(3):101641. PubMed ID: 35090894
[TBL] [Abstract][Full Text] [Related]
13. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice.
Wang Y; Wan Y; Ye G; Wang P; Xue X; Wu G; Ye B
Eur J Pharm Sci; 2016 Oct; 93():123-31. PubMed ID: 27516150
[TBL] [Abstract][Full Text] [Related]
15. An adiponectin-S1P autocrine axis protects skeletal muscle cells from palmitate-induced cell death.
Botta A; Elizbaryan K; Tashakorinia P; Lam NH; Sweeney G
Lipids Health Dis; 2020 Jul; 19(1):156. PubMed ID: 32611437
[TBL] [Abstract][Full Text] [Related]
16. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
[TBL] [Abstract][Full Text] [Related]
17. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
18. Kaempferide improves glycolipid metabolism disorder by activating PPARγ in high-fat-diet-fed mice.
Tang H; Zeng Q; Tang T; Wei Y; Pu P
Life Sci; 2021 Apr; 270():119133. PubMed ID: 33508298
[TBL] [Abstract][Full Text] [Related]
19. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
20. AdipoRon prevents myostatin-induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line.
Liu XH; Pan JP; Bauman WA; Cardozo CP
Physiol Rep; 2019 Aug; 7(13):e14152. PubMed ID: 31250564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
